Nemysis Limited | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
Nemysis Limited

BRIEF

published on 05/23/2024 at 10:05, 5 months 29 days ago

Nemysis Limited Announces the Grant of Further IP for its IHAT Oral Iron Supplement

Nutritional Supplement IHAT Patent Iron Deficiency Nemysis Limited
PRESS RELEASE

published on 05/23/2024 at 10:00, 5 months 29 days ago

Nemysis Limited Announces the Grant of Further IP for its IHAT Oral Iron Supplement
Nemysis strengthens IP portfolio with new patent (WO2021204705) for IHAT oral iron supplement, safe for iron deficiency treatment. Dr. Comelli and Dr. Faria comment on significance

IHAT Patent IP Portfolio Iron Deficiency Nemysis
PRESS RELEASE

published on 01/10/2024 at 17:00, 10 months 10 days ago

Nemysis Limited Signs With Kolinpharma SpA an IHAT Sales and Marketing Agreement
Nemysis Ltd and Kolinpharma® SpA have signed a non-exclusive sales and marketing agreement for IHAT (Iron Hydroxide Adipate Tartrate), Nemysis' innovative oral iron supplementation product. This partnership aims to enhance coverage of the target markets within Italy, one of the largest in Europe, and improve access to effective iron deficiency solutions.

Nemysis Ltd Kolinpharma® SpA IHAT Iron Supplementation Italy Market

Accesswire

Published on 11/21/2024 at 10:03, 53 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 56 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 56 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 21 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 31 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 25 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 51 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 53 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 55 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 55 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 58 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 36 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 11 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 11 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE